Evidence map›Paper›PMID 26729698›Full record

ArticlePediatrics2016

Supporting Parental Decisions About Genomic Sequencing for Newborn Screening: The NC NEXUS Decision Aid.

Megan A Lewis, Ryan S Paquin, Myra I Roche, Robert D Furberg, Christine Rini, Jonathan S Berg, Cynthia M Powell, Donald B Bailey

Registry-linked trialAbstract read
In one paragraph

Article in Pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05159011 (Access to Genetic Information Leveraging Innovative Technology), which is not on this map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05159011 nawithdrawnnot on this mapstarted 2023, after this paper: background citation

Access to Genetic Information Leveraging Innovative Technology

TypeinterventionalSponsorRTI InternationalRan2023 to 2025Enrolled0ConditionsGenetic TestingArmsAGILITY (Access to Genetic Information Leveraging Innovative TechnologY)
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Values clarification and parental decision making about newborn genomic sequencing.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2020
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Genomic newborn screening for rare diseases.Nature reviews. Genetics · 2023
    Review
  13. Newborn screening research sponsored by the NIH: From diagnostic paradigms to precision therapeutics.American journal of medical genetics. Part C, Seminars in medical genetics · 2022
    Article
  14. Article
  15. A Window of Opportunity for Newborn Screening.Molecular diagnosis & therapy · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Megan A LewisCenter for Communication Science, and melewis@rti.org.
Ryan S PaquinCenter for Communication Science, and.
Myra I RocheDepartment of Pediatrics, and Department of Genetics, and.
Robert D FurbergCenter for the Advancement of Health Information Technology.
Christine RiniLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Jonathan S BergDepartment of Genetics, and.
Cynthia M PowellDepartment of Pediatrics, and Department of Genetics, and.
Donald B BaileyRTI International, Research Triangle Park, North Carolina; and.

Funding

NC NEXUS, North Carolina Newborn Exome Sequencing for Universal ScreeningU19HD077632 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S, POWELL, CYNTHIA MARION · 2013 to 2018
$6.3M
NICHD NIH HHS U19 HD077632
6 · The paper itself

Abstract

Advances in genomic sequencing technology have raised fundamental challenges to the traditional ways genomic information is communicated. These challenges will become increasingly complex and will affect a much larger population in the future if genomics is incorporated into standard newborn screening practice. Clinicians, public health officials, and other stakeholders will need to agree on the types of information that they should seek and communicate to parents. Currently, few evidence-based and validated tools are available to support parental informed decision-making. These tools will be necessary as genomics is integrated into clinical practice and public health systems. In this article we describe how the North Carolina Newborn Exome Sequencing for Universal Screening study is addressing the need to support parents in making informed decisions about the use of genomic testing in newborn screening. We outline the context for newborn screening and justify the need for parental decision support. We also describe the process of decision aid development and the data sources, processes, and best practices being used in development. By the end of the study, we will have an evidenced-based process and validated tools to support parental informed decision-making about the use of genomic sequencing in newborn screening. Data from the study will help answer important questions about which genomic information ought to be sought and communicated when testing newborns.

Indexed as

Decision MakingDecision Support TechniquesGenetic TestingHigh-Throughput Nucleotide SequencingNeonatal ScreeningParentsExomeGenetic Predisposition to DiseaseGenome, HumanHealth EducationHumansInfant, NewbornInternetNorth CarolinaSequence Analysis, DNA

Identifiers

PMID26729698
PMCPMC4922487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.